Literature DB >> 20889678

miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide.

Yiguo Jiang1, Yan Wu, Anne R Greenlee, Jianjun Wu, Zhiyuan Han, Xun Li, Yao Zhao.   

Abstract

microRNAs (miRNAs) are an abundant class of small noncoding RNAs that function primarily as oncogenes and tumor suppressors by mediating translational repression or mRNA degradation via binding target genes. In this study, malignant human bronchial epithelial cells transformed by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide were used to help characterize the possible mechanisms of miRNA function in chemical carcinogenesis. The expression level of miR-106a was measured by the real-time, reverse transcriptase polymerase chain reaction. We used the miR-106a inhibitor and the miR-106a mimic to downregulate or upregulate miR-106a activity in malignantly transformed cells to determine the effects of miR-106a on the biological properties of the cell. We observed overrepresentation of miR-106a in transformed cells compared with control cells. Silencing miR-106a by transfection with the miR-106a inhibitor suppressed cell proliferation, induced cell cycle arrest and apoptosis, and inhibited anchorage-independent growth and tumor growth in nude mice. Increasing miR-106a in malignantly transformed cells by transfection with the miR-106a mimic gave the opposite results. Moreover, untransformed cells showed a reduction of cell cycle arrest and apoptosis rate followed by transfection with the miR-106a mimic. Bioinformatic analysis showed that tumor suppressor RB1 is one of predictive targets of miR-106a. We confirmed this target by Western blot and dual luciferase assay. Our findings suggest that miR-106a might function as an oncogene in transformation induced by a chemical carcinogen. Thus, knock down of miR-106a in malignant cells is a potential therapeutic strategy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20889678     DOI: 10.1093/toxsci/kfq306

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  9 in total

1.  Modulation of MicroRNAs by Chemical Carcinogens and Anticancer Drugs in Human Cancer: Potential Inkling to Therapeutic Advantage.

Authors:  Subrata Haldar; Aruna Basu
Journal:  Mol Cell Pharmacol       Date:  2011-01-01

2.  miR-CLIP capture of a miRNA targetome uncovers a lincRNA H19-miR-106a interaction.

Authors:  Jochen Imig; Andreas Brunschweiger; Anneke Brümmer; Boris Guennewig; Nitish Mittal; Shivendra Kishore; Panagiota Tsikrika; André P Gerber; Mihaela Zavolan; Jonathan Hall
Journal:  Nat Chem Biol       Date:  2014-12-22       Impact factor: 15.040

3.  Reversal and prevention of arsenic-induced human bronchial epithelial cell malignant transformation by microRNA-200b.

Authors:  Zhishan Wang; Yong Zhao; Eric Smith; Gregory J Goodall; Paul A Drew; Thomas Brabletz; Chengfeng Yang
Journal:  Toxicol Sci       Date:  2011-02-02       Impact factor: 4.849

4.  Human bronchial epithelial cells exposed in vitro to cigarette smoke at the air-liquid interface resemble bronchial epithelium from human smokers.

Authors:  Carole Mathis; Carine Poussin; Dirk Weisensee; Stephan Gebel; Arnd Hengstermann; Alain Sewer; Vincenzo Belcastro; Yang Xiang; Sam Ansari; Sandra Wagner; Julia Hoeng; Manuel C Peitsch
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2013-01-25       Impact factor: 5.464

5.  Angiotensin II-regulated microRNA 483-3p directly targets multiple components of the renin-angiotensin system.

Authors:  Jacqueline R Kemp; Hamiyet Unal; Russell Desnoyer; Hong Yue; Anushree Bhatnagar; Sadashiva S Karnik
Journal:  J Mol Cell Cardiol       Date:  2014-06-27       Impact factor: 5.000

6.  Circular RNA circNOL10 Inhibits Lung Cancer Development by Promoting SCLM1-Mediated Transcriptional Regulation of the Humanin Polypeptide Family.

Authors:  Aruo Nan; Lijian Chen; Nan Zhang; Yangyang Jia; Xin Li; Hanyu Zhou; Yihui Ling; Zhishan Wang; Chengfeng Yang; Sijin Liu; Yiguo Jiang
Journal:  Adv Sci (Weinh)       Date:  2018-11-16       Impact factor: 16.806

7.  Growth-promoting role of the miR-106a~363 cluster in Ewing sarcoma.

Authors:  Layne Dylla; Paul Jedlicka
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

8.  Feedback regulations of miR-21 and MAPKs via Pdcd4 and Spry1 are involved in arsenite-induced cell malignant transformation.

Authors:  Lu Shen; Min Ling; Yuan Li; Yuan Xu; Yun Zhou; Jing Ye; Ying Pang; Yue Zhao; Rongrong Jiang; Jianping Zhang; Qizhan Liu
Journal:  PLoS One       Date:  2013-03-01       Impact factor: 3.240

Review 9.  Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs.

Authors:  Eva Slabáková; Zuzana Kahounová; Jiřina Procházková; Karel Souček
Journal:  Noncoding RNA       Date:  2021-12-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.